FDA Clearance Tracker · P150011-S024
Perceval PLUS Sutureless Heart Valve
Last checked: Nov 20, 2026Latest source record: Oct 7, 2022 (this decision)Source: openFDAMethods & limitations
Decided
Oct 7, 2022
Approved
Time to decision
179 days
Received Apr 11, 2022. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P150011-S024
- Device name
- Perceval PLUS Sutureless Heart Valve
- Applicant
- Corcym S.r.l.
- Applicant location
- Saluggia
- Received
- Apr 11, 2022
- Decided
- Oct 7, 2022
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P150011
Device type
- Device type
- heart-valve, non-allograft tissue (LWR)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
approval for the Perceval RelyON PAK Accessories Kit for collapsing and releasing the Perceval PLUS valve and modification to the Instructions for Use to address the use of the new accessories.
Source documents
Other decisions for Corcym S.r.l.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K261707 · Decided Jun 18, 2026 · 27 days after receipt
Device type: Ring, Annuloplasty (KRH) · Cardiology
K260498 · Decided Apr 14, 2026 · 60 days after receipt
Device type: Ring, Annuloplasty (KRH) · Cardiology
K230318 · Decided Apr 7, 2023 · 60 days after receipt
Device type: Ring, Annuloplasty (KRH) · Cardiology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.